.6 mg semaglutide The Indian government has approved #NovoNordisk's obesity drug, Wegovy, for the treatment of #fattyliver disease. Novo Nordisk said the Central Drugs Standard Control Organisation (CDSCO) approved #Wegovy's 2.4 injection for Compounded Semaglutide & GLP-1 Weight

Add too much bacteriostatic water and your concentration drops, forcing you to inject larger volumes

Because semaglutide and other GLP-1 analogs act in the brain, when taking into account possible adverse effects during GLP-1 treatment, caution may be considered for the influence of semaglutide in the limbic system of the brain during an individualized approach

SOUL trial (Rybelsus, cardiovascular, October 2024): 9,650 patients with T2D and ASCVD/CKD

Gallstones are hard deposits in the gallbladder that can cause abdominal pain and severe nausea

Mar 25, 2026 Some people lose 20% of their body weight on tirzepatide